Brief: Jacobio Pharmaceuticals Posts FY Revenue RMB 155.7 Million
19/03/2025 13:04
Mar 19 (Reuters) - Jacobio Pharmaceuticals Group FY net income RMB -155.7 million. FY revenue RMB 155.7 million
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan